Analysis of Mammography BI-RADS Distribution and Follow-up Ultrasound Assessment: A Single-Center Study

被引:0
|
作者
Kankaya, Burak [1 ]
Buyukasik, Suleyman [1 ]
Altundal, Yusuf Emre [1 ]
Topcu, Feyza Sonmez [2 ]
Rahmanbakhsh, Paria [1 ]
Etemad, Ayden [1 ]
Kapan, Selin [1 ]
Alis, Halil [1 ]
机构
[1] Istanbul Aydin Univ, Fac Med, Dept Gen Surg, Besyol Mah Akasya Sok 4, TR-34295 Istanbul, Turkiye
[2] Istanbul Aydin Univ, Fac Med, Dept Radiol, Istanbul, Turkiye
来源
BREAST CANCER-TARGETS AND THERAPY | 2025年 / 17卷
关键词
breast ultrasonography; mammography; breast cancer; early diagnosis; BI-RADS classification; BREAST-CANCER;
D O I
10.2147/BCTT.S481201
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Our study has three main aims: 1) to assess the distribution of Breast Imaging Reporting and Data System (BI-RADS) classifications in a cohort of Turkish women undergoing screening mammography, 2) to analyze the frequency and non-completion rates of recommended follow-up ultrasound (US) examinations, and 3) to examine the outcomes of completed follow-up US examinations. Our goal was to evaluate potential gaps in the current breast cancer screening process by analyzing BI-RADS classifications, follow-up completion rates, and outcomes of completed ultrasound examinations. Patients and Methods: This retrospective study analyzed 1761 Turkish women who underwent screening mammography from 2020-2022 at the Istanbul Aydin University General Surgery Clinic, Istanbul, Turkey. We assessed the distribution of BI-RADS classifications, analyzed the frequency and non-completion rates of recommended follow-up US, and examined the outcomes of completed follow-up US examinations. Chi-square tests of independence and Spearman's rank correlation test were used to analyze the data. Results: Our study revealed three key findings: 1) Over half of mammograms (55.9%) were classified as BI-RADS 0, requiring further imaging. 2) Nearly one-third of patients who recommended US examinations (31.91%) did not complete recommended followup ultrasound appointments. 3) Among those who completed follow-up ultrasonography, almost one-third (29.7%) were reclassified as BI-RADS 3 or higher. Notably, 2.3% (n=18) were classified as BI-RADS 4 or 5, suggesting findings suspicious for malignancy. Conclusion: Our findings highlight the crucial role of follow-up US in breast cancer screening. The high rate of initial BI-RADS 0 classifications using mammography, coupled with the significant non-completion rate for follow-up US examinations, particularly among older age groups, highlights potential gaps in the current screening process.
引用
收藏
页码:115 / 122
页数:8
相关论文
共 45 条
  • [41] Incidence and natural course of CT-detected pulmonary ground-glass nodules in Chinese women with breast cancer: a retrospective, single-center, long-term follow-up study in 4682 consecutive patients
    Xu, Hai
    Pu, Xue-Hui
    Yu, Tong-Fu
    Shi, Hai-Bin
    Wu, Yan-Ling
    Xu, Yi-Ming
    Feng, Qing
    ACTA RADIOLOGICA, 2020, 61 (02) : 175 - 183
  • [42] Neoadjuvant therapy with doxorubicin-cyclophosphamide followed by weekly paclitaxel in early breast cancer: a retrospective analysis of 200 consecutive patients treated in a single center with a median follow-up of 9.5 years
    Dredze, Lisi M.
    Friger, Michael
    Ariad, Samuel
    Koretz, Michael
    Delgado, Bertha
    Shaco-Levy, Ruthy
    Tokar, Margarita
    Bayme, Michael
    Agassi, Ravit
    Rosenthal, Maia
    Dyomin, Victor
    Belochitski, Olga
    Libson, Shai
    Mizrahi, Tamar
    Geffen, David B.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 193 (03) : 597 - 612
  • [43] Neoadjuvant therapy with doxorubicin-cyclophosphamide followed by weekly paclitaxel in early breast cancer: a retrospective analysis of 200 consecutive patients treated in a single center with a median follow-up of 9.5 years
    Lisi M. Dredze
    Michael Friger
    Samuel Ariad
    Michael Koretz
    Bertha Delgado
    Ruthy Shaco-Levy
    Margarita Tokar
    Michael Bayme
    Ravit Agassi
    Maia Rosenthal
    Victor Dyomin
    Olga Belochitski
    Shai Libson
    Tamar Mizrahi
    David B. Geffen
    Breast Cancer Research and Treatment, 2022, 193 : 597 - 612
  • [44] Predicting invasive disease-free survival in ER-positive, HER2-negative early breast cancer using the PAM50 risk-of-recurrence score: a retrospective analysis using single-center long-term follow-up data of postmenopausal Japanese patients
    Higami, Akane
    Takada, Masahiro
    Kawaguchi-Sakita, Nobuko
    Kawashima, Masahiro
    Kawaguchi, Kosuke
    Yamaguchi, Ayane
    Takeuchi, Yasuhide
    Yamada, Yosuke
    Toi, Masakazu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (11) : 1715 - 1720
  • [45] An XGBoost Machine Learning Based Model for Predicting Ki-67 Value ≥ 15% in T2NXM0 Stage Primary Breast Cancer Receiving Neoadjuvant Chemotherapy Using Clinical Data and Delta-Radiomic Features on Ultrasound Images and Overall Survival Analysis: A 5-Year Postoperative Follow-Up Study
    Lu, Yang
    Yang, Fei
    Tao, Yichao
    An, Pang
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23